Adrafinil and modafinil are so closely related that describing one almost requires describing the other. Adrafinil came first, developed in France in the 1970s as a treatment for excessive sleepiness in older adults. Researchers soon noticed that adrafinil’s effects were largely produced by a metabolite the body made from it, and that metabolite turned out to be modafinil. Modafinil was then developed as a drug in its own right, went on to become the far more widely prescribed compound, and adrafinil faded into the background, eventually being discontinued by its manufacturer.
Despite that history, adrafinil is still discussed and sought out, partly because in some countries it has been easier to obtain than prescription modafinil. That makes an honest comparison worthwhile. This article covers how the two differ in onset, effective potency, and, most importantly, what the liver has to do with all of it.
The Prodrug Relationship
The single most important fact about adrafinil is that it is a prodrug. A prodrug is a compound that is not very active on its own and must be converted by the body into an active form. In adrafinil’s case, the conversion happens in the liver, where enzymes strip a hydroxyl group from the molecule to produce modafinil. A portion of adrafinil is also converted into an inactive acid metabolite that goes nowhere useful.
So when you take adrafinil, what ultimately reaches the brain and promotes wakefulness is modafinil. There is no separate “adrafinil effect” distinct from modafinil’s. Everything about mechanism, meaning dopamine transporter inhibition with downstream orexin and histamine activation, is shared, because it is literally the same active molecule doing the work.
The differences, then, are not in what the drug does but in the route it takes to get there, and that route changes three things: how quickly it starts, how much of the dose becomes active, and how much work the liver has to do.
Onset: Why Adrafinil Is Slower
Modafinil taken by mouth is absorbed and reaches peak blood levels in roughly two to four hours. Users generally notice the effect within an hour or so. Adrafinil must first be absorbed and then metabolized in the liver into modafinil before the active compound can accumulate, which adds a delay. In practice, the onset of adrafinil is noticeably slower, often a further hour or more on top of modafinil’s own onset, and the rise in effect is more gradual.
This matters in two ways:
- Planning. If you want to be alert by 9 a.m., modafinil at 7 a.m. works. Adrafinil at 7 a.m. may not deliver its full effect until closer to 10 a.m.
- Dosing mistakes. A slow onset tempts people into taking a second dose because “the first one did nothing,” only to have both arrive at once. This is a common error with prodrugs of every kind.
Duration after onset
Once adrafinil has been converted, the resulting modafinil behaves like any other modafinil, with a half-life of roughly 12 to 15 hours. The overall duration of adrafinil’s effect is therefore similar to modafinil’s, just shifted later by the conversion delay. Some users report the tail end feeling slightly longer, which is consistent with continued conversion of remaining adrafinil over the first several hours.
Potency: Milligram for Milligram, Adrafinil Is Weaker
Because only part of an adrafinil dose becomes modafinil, adrafinil must be taken in larger quantities to produce a comparable effect. Historically, adrafinil was dosed at 300 to 600 mg, compared with 100 to 200 mg for modafinil. Rough rule-of-thumb comparisons often place 300 mg of adrafinil somewhere near 100 mg of modafinil in effect, though the conversion is inefficient and variable between people, so this is an approximation rather than a fixed ratio.
The variability itself is a drawback. Liver enzyme activity differs from person to person and is influenced by genetics, other medications, age, and general liver health. Two people taking the same adrafinil dose may end up with meaningfully different modafinil levels. Modafinil, entering the body already active, bypasses that source of variation.
There is also a subtle point about peak intensity. Because adrafinil is converted gradually rather than absorbed all at once as active drug, its peak modafinil concentration is generally lower and broader than what a direct modafinil dose produces. Some users describe adrafinil as “smoother” for this reason; others describe it as “weaker.” Both are describing the same pharmacokinetic fact.
Liver Considerations: The Real Divide
If onset and potency were the only differences, adrafinil would simply be a slower, less efficient way to take modafinil. The liver is what turns this into a genuine safety distinction.
Converting adrafinil to modafinil is metabolic work performed by the liver. With occasional use, this is unlikely to matter. With chronic daily use, however, elevations in liver enzymes have been reported, which is a sign the liver is under strain. This concern was noted during adrafinil’s years on the market and is one reason the drug was never pursued as vigorously once modafinil became available. Modafinil does pass through the liver as well, since it is metabolized there, but it does not require the initial conversion step, and liver-enzyme elevation is not a prominent concern in its long-term clinical use.
Cephalon, which came to own both compounds, discontinued adrafinil. The commercial logic was obvious: modafinil did everything adrafinil did, more predictably and with less liver burden, so there was little reason to keep the older drug.
What “liver enzyme elevation” means in practice
Elevated liver enzymes on a blood test do not necessarily mean liver damage, but they indicate the liver is being stressed. Sustained elevation over months can precede real harm. Anyone using adrafinil regularly, which is not recommended, would at minimum need periodic liver function tests, should avoid alcohol and other liver-stressing substances, and should stop if enzymes rise. This monitoring requirement is essentially absent from routine modafinil use in healthy people.
Side-by-Side Comparison
| Feature | Adrafinil | Modafinil |
| Status | Prodrug; converted to modafinil in the liver | Active drug |
| Historical dose | 300 to 600 mg | 100 to 200 mg |
| Onset | Slower, often an extra hour or more | Around one hour to noticeable effect, peak at two to four hours |
| Peak intensity | Lower, broader | Higher, more defined |
| Duration | Similar once converted, shifted later | Half-life about 12 to 15 hours |
| Person-to-person variability | Higher, depends on liver enzyme activity | Lower |
| Liver burden | Higher; enzyme elevations with chronic use | Lower; standard hepatic metabolism |
| Regulatory status in the US | Unscheduled, not approved as a drug | Schedule IV prescription medication |
| Manufacturer status | Discontinued by Cephalon | Widely available as generic |
Why People Still Choose Adrafinil
Given all of the above, why does adrafinil persist? Three reasons come up repeatedly.
Access. In several countries, adrafinil has been sold as an unregulated compound while modafinil requires a prescription. For someone who cannot or does not want to obtain a prescription, adrafinil has looked like a legal route to a modafinil-like effect. Regulations change and vary by country, and this is not a reason to skip talking with a doctor.
Perceived smoothness. The gradual conversion produces a gentler onset that some people find more comfortable than modafinil’s more distinct arrival.
Novelty and curiosity. Adrafinil sits in the nootropic and smart drug conversation as the “original” eugeroic, and some people simply want to try it.
None of these change the pharmacology. What you get from adrafinil is modafinil, arriving later, in a less predictable amount, at the cost of extra liver work.
Practical Guidance If Comparing the Two
For anyone weighing these compounds, a few principles hold up.
- If modafinil is available to you legally with medical guidance, it is the better choice on every axis except perhaps the subjective smoothness of onset, which can be approximated by taking modafinil with food and starting at 100 mg.
- If adrafinil is used at all, it should be occasional, not daily. The liver concern is dose- and duration-dependent.
- Do not redose adrafinil because the first dose “did nothing” within the first hour. Wait the full onset period.
- Take either compound early in the morning. The long half-life of the active modafinil applies to both, and adrafinil’s delayed onset pushes the effective window even later.
- Avoid alcohol and other liver-metabolized substances on adrafinil days.
- Get baseline liver function tests before any repeated adrafinil use, and follow up periodically.
A brief responsible-use note: modafinil is a prescription medication in the United States and many other countries, and adrafinil’s legal status varies widely. Talk with a doctor before using either, particularly if you have liver or heart conditions or take other medications. Neither is a replacement for sleep.
Frequently Asked Questions
Is adrafinil just a weaker modafinil? Effectively, yes. Adrafinil is converted into modafinil in the liver, with only part of the dose becoming active, so larger amounts are needed and the effect arrives later and more gradually.
How long does adrafinil take to work compared to modafinil? Modafinil is usually noticeable within an hour. Adrafinil typically takes an hour or more beyond that because the liver must convert it first, and the effect builds more slowly.
Is adrafinil safer because it is unscheduled? No. Scheduling reflects abuse potential and regulatory history, not liver safety. Adrafinil carries the additional liver burden that modafinil does not, and it is not approved as a medicine in the United States.
Can I take adrafinil every day? Chronic daily use is where liver enzyme elevations have been reported. It is not recommended, and anyone doing it should have liver function monitored.
What about armodafinil in this comparison? Armodafinil is the R-enantiomer of modafinil, so it sits on the modafinil side of the divide: direct-acting, predictable, prescription-only, and without adrafinil’s conversion step or added liver work.
Final Thoughts
Adrafinil and modafinil deliver the same active molecule to the brain by different routes. Modafinil arrives ready to work, with a defined onset, predictable dosing, and decades of clinical data behind it. Adrafinil arrives only after the liver converts it, which makes it slower, less potent per milligram, more variable between individuals, and harder on the organ doing the conversion. Its persistence owes more to access and history than to any pharmacological advantage. If you are choosing between the two as a wakefulness-promoting agent, the honest conclusion is that adrafinil is the compound modafinil was created to replace, and for good reason.
For more topic guides and related resources, visit Modavance.
